At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients
In Brief
A Phase 2 clinical trial evaluating Dexamethasone, Placebo, and 1 other intervention for Dyspnea and Malignant Neoplasm. Active but no longer recruiting, targeting 135 participants across 3 sites.
Signals
Detailed Summary
This phase II trial studies how well dexamethasone works in controlling dyspnea in patients with cancer. Dexamethasone may help control dyspnea (shortness of breath) and improve lung function and quality of life in cancer patients.
Study Details
Timeline
Arms & Interventions
Patients receive dexamethasone PO BID on days 1-28 in the absence of disease progression or unacceptable toxicity.
Patients receive placebo PO BID on days 1-14 and dexamethasone PO BID on days 15-28 in the absence of disease progression or unacceptable toxicity.
Interventions
Given PO
Given PO
Ancillary studies